Filing Details

Accession Number:
0001062993-22-022319
Form Type:
13D Filing
Publication Date:
2022-11-15 19:00:00
Filed By:
Edenbrook Capital, Llc
Company:
Brightcove Inc (NASDAQ:BCOV)
Filing Date:
2022-11-16
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Edenbrook Capital 0 5,608,490 0 5,608,490 5,608,490 13.33%
Jonathan Brolin 0 5,608,490 0 5,608,490 5,608,490 13.33%
Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,  D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934 (Amendment No. 8)

Brightcove, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

10921T101

(CUSIP Number)

Jonathan Brolin
Edenbrook Capital, LLC
116 Radio Circle

Mount Kisco, NY 10549
(
914) 239-3117

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 14, 2022

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d -1( e), 240.13d -l(f) or 240.13d -l(g), check the following box [ ].

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1/6

SCHEDULE 13D

CUSIP No. 10921T101

1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Edenbrook Capital, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a) [ ]
(b) [ ]
3 SEC USE ONLY


4 SOURCE OF FUNDS (See Instructions)
 
AF
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
 
[ ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION
 
New York
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER
 
-0-
8 SHARED VOTING POWER
 
5,608,490
9 SOLE DISPOSITIVE POWER
 
-0-
10 SHARED DISPOSITIVE POWER
 
5,608,490
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
5,608,490
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[ ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.33%
14 TYPE OF REPORTING PERSON (See Instructions)
 
IA,00
       

2/6

Page 3

SCHEDULE 13D

CUSIP No. 10921T101

1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Jonathan Brolin
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a) [ ]
(b) [ ]
3 SEC USE ONLY


4 SOURCE OF FUNDS (See Instructions)
 
AF
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
 
[ ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER
 
-0-
8 SHARED VOTING POWER
 
5,608,490
9 SOLE DISPOSITIVE POWER
 
-0-
10 SHARED DISPOSITIVE POWER
 
5,608,490
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
5,608,490
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[ ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.33%
14 TYPE OF REPORTING PERSON (See Instructions)
 
IN
       

3/6

Page 4

This Amendment No. 8 ("Amendment No. 8") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on June 19, 2019, as subsequently amended on Schedule 13D (as amended thereby and hereby, the "Schedule 13D"), with respect to the Common Stock, par value $0.001 (the "Common Stock") of Brightcove, Inc. (the "Issuer"). Capitalized terms used herein and not otherwise defined in this Amendment No. 8 have the meanings set forth in the Schedule 13D. This Amendment No. 8 amends Items 3 and 5 as set forth below.

Item 3. Source and Amount of Funds or Other Considerations

Shares reported represent 5,608,490 shares of the Common Stock of the Issuer.

The net investment costs (including commissions, if any) of the Common Stock directly owned by the private investment funds advised by Edenbrook is approximately $47,570,539. The Common Stock was purchased with the investment capital of the private investment funds advised by Edenbrook.

Item 5. Interest in Securities of the Issuer

(a) As of the date hereof , (i) Edenbrook and Mr. Brolin may be deemed to be the beneficial owners of 5,608,490 shares of Common Stock, constituting 13.28% of the shares of Common Stock, based upon 42,072,217 shares of Common Stock outstanding as of October 28, 2022, based on the information set forth in the Quarterly Report on form 10-Q filed by the Issuer on November 2, 2022.

(b) Edenbrook and Mr. Brolin have the sole power to vote or direct the vote of 0 shares of Common Stock; have the shared power to vote or direct the vote of 5,608,490 shares of Common Stock; have the sole power to dispose or direct the disposition of 0 shares of Common Stock; and have the shared power to dispose or direct the disposition of 5,608,490 shares of Common Stock.

4/6

Page 5

(c) The transactions by the Reporting Persons in the securities of the Issuer since the last filing are set forth in Schedule A.  All such transactions were carried out in open market transactions.

(d) No person other than the Reporting Persons and the private investment funds advised by Edenbrook are known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock held  by the Fund and the other private investment funds advised by Edenbrook.

(e) Not applicable


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

November 16, 2022
Dated

 

EDENBROOK CAPITAL, LLC

/s/ Jonathan Brolin
Name
: Jonathan Brolin

Title: Managing Member

/s/ Jonathan Brolin
JONATHAN BROLIN

5/6

Schedule A

Trade Date Transaction  Quantity Price
9/23/2022 Buy 16,946 6.4222
9/26/2022 Buy 2,131 6.3983
9/27/2022 Buy 21,763 6.3995
9/27/2022 Buy 50,000 6.41
9/28/2022 Buy 2,539 6.4
9/29/2022 Buy 60,000 6.3878
9/30/2022 Buy 27,110 6.34
10/10/2022 Buy 20,000 6.4
10/11/2022 Buy 12,500 6.2933
10/12/2022 Buy 6,800 6.2477
10/13/2022 Buy 2,904 6.1682
10/27/2022 Buy 2,362 6.5
10/28/2022 Buy 1,457 6.5
11/3/2022 Buy 10,976 5.9836
11/4/2022 Buy 31,029 5.9065
11/7/2022 Buy 30,000 5.5628
11/7/2022 Buy 70,000 5.6017
11/8/2022 Buy 50,000 5.3994
11/9/2022 Buy 28,789 5.216
11/14/2022 Buy 30,000 5.553
11/14/2022 Buy 7,193 5.5
11/15/2022 Buy 1,000 5.497
11/15/2022 Buy 3,060 5.5
11/16/2022 Buy 10,775 5.4876
11/16/2022 Buy 9,913 5.4955


6/6